Patent · US Active

Azetidine 2-carboxamide derivatives which modulate the CB2 receptor

US8383615B2 · kind B2 · utility

6Cited by

40References

17Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Eugene Richard Hickey · Danbury, US
Doris Riether · Biberach an der Riß, DE
David Thomson · Ridgefield, US
Lifen Wu · New Milford, US
Renee M. Zindell · New Milford, US

Key dates

Filing date	Jun 8, 2010
Grant date	Feb 26, 2013
Priority date	—
Expiry date	Jun 8, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D417/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds of the formula (I), (II) and (III) which modulate the CB2 receptor are disclosed. Compounds according to the invention bind to and are agonists of the CB2 receptor, and are useful for treating inflammation. Those compounds which are agonists are additionally useful for treating pain.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.